BridgeMD
New treatment option for Acute Pulmonary Embolism
Official title Incorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary Embolism
ClinicalTrials.gov ID: NCT06784492
What this study is testing
- What it's testing
- The purpose of the ERAsE-PE study is to determine whether two different healthy living strategies (along with anticoagulation) might aid in recovery after a patient is hospitalized for pulmonary embolism. Specifically, Investigators will compare changes in Cardiac Effort (#heart beats used during the 6-minute walk test/walk distance) measured after an 8-week program.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- English speaking (\>18 years old). Daily messages will be sent in English.
- Acute PE with at least one of the following:
- any right ventricular enlargement or dysfunction on echocardiogram;
- CT Angiogram reporting any right ventricular enlargement; or
- elevated cardiac biomarker (NT-pro BNP or troponin above baseline). Criteria for enrollment will be included on source document.
You likely can't join if
- Pregnancy.
- Cardiac Effort \>3.5 beats/m during 6MWT.
- Resting tachycardia \>110 beats/m at hospital discharge.
- Chronic Thromboembolic Pulmonary Hypertension
- Systolic blood pressure \>180 mmHg at hospital discharge.
- Inability to walk.
See the full eligibility criteria
- English speaking (\>18 years old). Daily messages will be sent in English.
- Acute PE with at least one of the following:
- any right ventricular enlargement or dysfunction on echocardiogram;
- CT Angiogram reporting any right ventricular enlargement; or
- elevated cardiac biomarker (NT-pro BNP or troponin above baseline). Criteria for enrollment will be included on source document.
- Rate controlled atrial arrythmias (resting heart rate \<110 beats/m) are eligible for enrollment. This includes atrial fibrillations. This is standard of care management for atrial fibrillation.
- people do need to take prescribed anticoagulation.
- Pregnancy.
- Cardiac Effort \>3.5 beats/m during 6MWT.
- Resting tachycardia \>110 beats/m at hospital discharge.
- Chronic Thromboembolic Pulmonary Hypertension
- Systolic blood pressure \>180 mmHg at hospital discharge.
- Inability to walk.
- Estimated prognosis \<12 months at the time of discharge due to underlying co-morbidities (e.g., cancer).
- Advanced neurologic disease and would not be able to comply with the messages.
- Lack of access to email or text messaging 10. Inability or unwillingness to follow daily instructions.
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.